ABOUT THE SERVICE
CAMCEVI® is a biosimilar to Neupogen® (filgrastim), used in the treatment of adult patients with advanced prostate cancer. It’s a key part of our commitment to providing accessible oncology therapies.
Information is owner-confirmed
Last updated 1 month ago
Price range
Other products/services from Accord BioPharma
HERCESSI™ (trastuzumab-strf)
Pharmaceutical
N/A
Accord BioPharma
United States (US)